What does APOTHEEK SCHEVELENBOS do?

APOTHEEK SCHEVELENBOS is a pharmacy in Wuustwezel. Public Limited, started on 5 December 1986, 1 establishment.

What is the address of APOTHEEK SCHEVELENBOS?

The registered office of APOTHEEK SCHEVELENBOS is located at Kapelstraat 11, 2990 Wuustwezel.

Is APOTHEEK SCHEVELENBOS still active?

Yes. According to the CBE (30 October 2026) APOTHEEK SCHEVELENBOS is active, legal situation “Normale toestand”, started on 5 December 1986.

Is APOTHEEK SCHEVELENBOS registered on Peppol?

Yes, APOTHEEK SCHEVELENBOS is registered on the Peppol network with ID 0208:0429997535.

What is the enterprise number of APOTHEEK SCHEVELENBOS?

The enterprise number of APOTHEEK SCHEVELENBOS is BE0429997535.

When was APOTHEEK SCHEVELENBOS founded?

APOTHEEK SCHEVELENBOS was founded on 5 December 1986.

Who are the directors of APOTHEEK SCHEVELENBOS?

According to the 2025 annual accounts, the directors of APOTHEEK SCHEVELENBOS are: VS BV.

Is APOTHEEK SCHEVELENBOS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 5 December 1986; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK SCHEVELENBOS make in 2025?

APOTHEEK SCHEVELENBOS posted a profit after taxes of € 178,620 in financial year 2025.

What is the revenue of APOTHEEK SCHEVELENBOS?

As a small company, APOTHEEK SCHEVELENBOS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 336,110.

How much does an employee at APOTHEEK SCHEVELENBOS earn?

The average wage cost per full-time employee at APOTHEEK SCHEVELENBOS was € 81,200 in 2025: staff costs of € 105,503 for 1.3 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK SCHEVELENBOS have?

According to the 2025 annual accounts, APOTHEEK SCHEVELENBOS has 1.3 full-time equivalents (FTE).

APOTHEEK SCHEVELENBOS (Public Limited) - Wuustwezel

Dossier APOTHEEK SCHEVELENBOS, printed on 30 October 2026 from databakkes.be/en/0429997535/apotheek-schevelenbos. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK SCHEVELENBOS from Wuustwezel, company number BE0429997535, closed financial year 2025 with a result of € 178,620 after tax. For that financial year APOTHEEK SCHEVELENBOS recorded a gross margin of € 336,110 and equity of € 421,258. Compared with financial year 2024, the result moved from € 187,141 to € 178,620. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 22, 2026.

What it is worth Growing

€ 421,258

▲ 16% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 178,620

▼ 5% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 286,024

▲ 1% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 120,000 paid out

67 % of the profit went to the shareholders, mostly to VS (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

1.3

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 105,503

▲ 3% vs 2024

€ 81,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 49,544

▼ 25% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 45,522

▼ 40% vs 2024

€ 14,423 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 101,825

▼ 5% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 19,922

▼ 9% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 291,455 Gross margin 2022: € 291,455 First fiscal year in the series	€ 297,535 Gross margin 2023: € 297,535 ▲ 2% vs 2022 (€ 291,455) Favourable step	€ 385,876 Gross margin 2024: € 385,876 ▲ 30% vs 2023 (€ 297,535) Favourable step	€ 336,110 Gross margin 2025: € 336,110 ▼ 13% vs 2024 (€ 385,876) Unfavourable step	▼ 13%
Profit after taxes	€ 130,696 Profit after taxes 2022: € 130,696 First fiscal year in the series	€ 130,717 Profit after taxes 2023: € 130,717 Unchanged (€ 130,696) Favourable step	€ 187,141 Profit after taxes 2024: € 187,141 ▲ 43% vs 2023 (€ 130,717) Favourable step	€ 178,620 Profit after taxes 2025: € 178,620 ▼ 5% vs 2024 (€ 187,141) Unfavourable step	▼ 5%
Equity	€ 249,781 Equity 2022: € 249,781 First fiscal year in the series	€ 300,498 Equity 2023: € 300,498 ▲ 20% vs 2022 (€ 249,781) Favourable step	€ 362,638 Equity 2024: € 362,638 ▲ 21% vs 2023 (€ 300,498) Favourable step	€ 421,258 Equity 2025: € 421,258 ▲ 16% vs 2024 (€ 362,638) Favourable step	▲ 16%
Total debts	€ 283,710 Total debts 2022: € 283,710 First fiscal year in the series	€ 250,244 Total debts 2023: € 250,244 ▼ 12% vs 2022 (€ 283,710) Favourable step	€ 329,594 Total debts 2024: € 329,594 ▲ 32% vs 2023 (€ 250,244) Unfavourable step	€ 287,559 Total debts 2025: € 287,559 ▼ 13% vs 2024 (€ 329,594) Favourable step	▼ 13%
Cash	€ 179,082 Cash 2022: € 179,082 First fiscal year in the series	€ 201,082 Cash 2023: € 201,082 ▲ 12% vs 2022 (€ 179,082) Favourable step	€ 283,618 Cash 2024: € 283,618 ▲ 41% vs 2023 (€ 201,082) Favourable step	€ 286,024 Cash 2025: € 286,024 ▲ 1% vs 2024 (€ 283,618) Favourable step	▲ 1%
Land & buildings	€ 18,852 Land & buildings 2022: € 18,852 First fiscal year in the series	€ 8,868 Land & buildings 2023: € 8,868 ▼ 53% vs 2022 (€ 18,852) Unchanged	-	-
Retained profit	€ 188,281 Retained profit 2022: € 188,281 First fiscal year in the series	€ 238,998 Retained profit 2023: € 238,998 ▲ 27% vs 2022 (€ 188,281) Favourable step	€ 301,138 Retained profit 2024: € 301,138 ▲ 26% vs 2023 (€ 238,998) Favourable step	€ 359,758 Retained profit 2025: € 359,758 ▲ 19% vs 2024 (€ 301,138) Favourable step	▲ 19%
Dividend	€ 80,000 Dividend 2022: € 80,000 First fiscal year in the series	€ 80,000 Dividend 2023: € 80,000 Unchanged (€ 80,000) Unchanged	€ 125,000 Dividend 2024: € 125,000 ▲ 56% vs 2023 (€ 80,000) Unchanged	€ 120,000 Dividend 2025: € 120,000 ▼ 4% vs 2024 (€ 125,000) Unchanged	▼ 4%
Bank debt	€ 78,394 Bank debt 2022: € 78,394 First fiscal year in the series	€ 49,781 Bank debt 2023: € 49,781 ▼ 36% vs 2022 (€ 78,394) Favourable step	€ 76,082 Bank debt 2024: € 76,082 ▲ 53% vs 2023 (€ 49,781) Unfavourable step	€ 45,522 Bank debt 2025: € 45,522 ▼ 40% vs 2024 (€ 76,082) Favourable step	▼ 40%
Balance sheet total	€ 533,491 Balance sheet total 2022: € 533,491 First fiscal year in the series	€ 550,742 Balance sheet total 2023: € 550,742 ▲ 3% vs 2022 (€ 533,491) Unchanged	€ 692,232 Balance sheet total 2024: € 692,232 ▲ 26% vs 2023 (€ 550,742) Unchanged	€ 708,817 Balance sheet total 2025: € 708,817 ▲ 2% vs 2024 (€ 692,232) Unchanged	▲ 2%
Employees (FTE)	1.3 Employees (FTE) 2022: 1.3 First fiscal year in the series	1.3 Employees (FTE) 2023: 1.3 Unchanged (1.3) Unchanged	1.3 Employees (FTE) 2024: 1.3 Unchanged (1.3) Unchanged	1.3 Employees (FTE) 2025: 1.3 Unchanged (1.3) Unchanged

Key figures of APOTHEEK SCHEVELENBOS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK SCHEVELENBOS?

What happened at APOTHEEK SCHEVELENBOS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 22, 2026 New annual accounts for financial year 2025: profit of € 178,620 (▼ 5% vs 2024). Source: NBB ↗
Jan 12, 1987 New establishment in Wuustwezel. KBO
Dec 5, 1986 Start of the company according to the CBE. KBO

In short

From € 130,696 profit in 2022 to € 178,620 profit in 2025.

Paid € 83,064 in corporate taxes since 2022.

Best year ever: 2024, with € 187,141 profit.

On average € 258,500 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

VS 100%

The stake of VS comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK SCHEVELENBOS

Behind APOTHEEK SCHEVELENBOS is VS BV. The shares are held by VS (100%).

Directors

According to the 2025 annual accounts

VS BV

Managing director · represented by Veerle Schevelenbos

Shareholders

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Kapelstraat 11

2990 Wuustwezel

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

VS same network

€ 206,590 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0429.997.535

VAT number

BE 0429.997.535

Registered office

Kapelstraat 11, 2990 Wuustwezel

Names & denominations

APOTHEEK SCHEVELENBOS

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

5 December 1986

Peppol

Active · Active since 16 Oct 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK SCHEVELENBOS

Financials

What happened to APOTHEEK SCHEVELENBOS?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions